Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12625000589482p
Ethics application status
Submitted, not yet approved
Date submitted
20/05/2025
Date registered
6/06/2025
Date last updated
6/06/2025
Date data sharing statement initially provided
6/06/2025
Type of registration
Prospectively registered
Titles & IDs
Public title
Investigating red light therapy in managing post operative pain after dental extractions
Query!
Scientific title
A trial comparing the efficacy of polychromatic light-emitting diode therapy in managing post operative pain following dental extractions (simple or surgical) in adults
Query!
Secondary ID [1]
314504
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Dental analgesia
337567
0
Query!
Postoperative pain
337568
0
Query!
Dental extractions
337678
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
333915
333915
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Anaesthesiology
333916
333916
0
0
Query!
Pain management
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Objective: Compare the efficacy of post operative pain after dental extractions with a multiwavelength light emitting diode (LED) device (Nuralyte®, Dentroid Canberra, Australia) to sham exposure.
Intervention: Participants will be attending a dental appointment for a dental extraction (simple or surgical). They will then be randomly chosen to receive either a light emitting diode with the Nuralyte® device for 2-4 minutes or a placebo (inactive light). After the dental extraction, they will be asked to report the level of discomfort on days 2,3,4 via mobile text message.
• Group 1: Placebo – 1 minute buccal and 1 minute lingual of socket = 2min total
• Group 2: Blend mode - 1 minute buccal and 1 minute lingual of socket = 2min total
• Group 3: Boost mode - 2 minute buccal and 2 minute lingual of socket = 4min total
This study will test the effects on post-operative pain of two different light wavelengths from the LED array in the Nuralyte. The device uses a custom-build LED array that has 4 separate LED emitters (700, 850, 970 and 1050 nm). The spectral width of the emitted light from each of these emitters is as follows (40 nm width, 60 nm width, 160 nm width, 100 nm width).
The first of the light wavelengths to be tested is 1050 nm. This wavelength is very similar to that of the Nd:YAG ( neodymium-doped yttrium aluminum garnet; Nd:Y3Al5O12) laser (1064 nm), which has known analgesic actions when used for treating pain. For this, the Nuralyte will be used in "Boost" mode, where only the 1050 nm LED light is powered. This 1010 nm LED emitter delivers an optical power of 300 mW. An exposure time of 60 seconds will give a delivered dose to the site of 18 Joules.
The second setting is to use all 4 different light wavelengths in combination (i.e. 700, 850, and 970 nm as well as 1050 nm). The rationale here is that each of the 3 shorter wavelengths also can contribute to analgesic pain-relieving actions. For this, the Nuralyte will be used in "Blend" mode, where all 4 LEDs operate simultaneously to deliver light from the device. When all 4 LEDs operate, the total combined optical power of is 1000 mW (i.e. 300 mW from 1050 nm, plus a total of 700 mW from the 3 other LEDs). As the total power is greater in Blend mode than Boost mode, the exposure time on Blend mode will be only 20 seconds rather than 60 seconds, so that the delivered dose to the treated site remains comparable, at 20 Joules.
Who will deliver the intervention
This trial will be undertaken by a registered general dentist or dental specialist. The intervention will administered in a clinical setting utilising appropriate personal protective equipment and following manufacturer instructions.
Location where intervention will occur
The study will occur at private practice dental clinics in Queensland, Australia (multi-centre study).
Participant selection
Adult dental patients (aged 18 years and above) who require a dental extraction as part of routine dental treatment will be invited to participate in the study. The registered dental practitioner or registered dental specialist will screen the patient and those who adhere to the inclusion criteria will be invited to participate.
Mode of delivery/number of times delivered
Each participant will be randomly selected to receive application of either sham exposure or the Nuralyte® device immediately after the completion of the dental extraction.
The registered general dental practitioner or dental specialist will also be required to record the following parameters at the time of the appointment on the provided data collection sheet:
• Tooth of interest (Federeal dental international notation), patient age and gender
• Type of extraction – simple, sectional, surgical (311,314,322,324)
• If flap was raised, if bone was removed
• Pell & Gregory classification if lower 3rd molar
• Approximate time of procedure
• Local anaesthetic given and amount given
• Clinician rating complexity of procedure
• If performed under local anaesthetic, nitrous, intravenous sedation or general anaesthetic
• Dentist name and clinic location
• Patient mobile number
• Reported visual analogue (VAS) pain scale for adult participants (score 1-10) on days 2,3,4
Query!
Intervention code [1]
331125
0
Treatment: Devices
Query!
Comparator / control treatment
Sham irradiation (also known as Placebo). The sham irradiation will involve placing the device in the patients mouth and applying it to the area of interest for 60 seconds however the device is not switched on. As the device is in the mouth, the patient will not be aware whether they are received treatment or the placebo.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
341559
0
Post operative discomfort after dental extraction
Query!
Assessment method [1]
341559
0
VAS pain scale for adults
Query!
Timepoint [1]
341559
0
Days 2,3,4 (after dental extraction)
Query!
Secondary outcome [1]
447930
0
Difficulty of dental extraction
Query!
Assessment method [1]
447930
0
Clinician rating with Likert scale
Query!
Timepoint [1]
447930
0
During dental extraction
Query!
Eligibility
Key inclusion criteria
Adult dental patients (aged 18 years and above) who require a dental extraction as part of routine dental treatment will be invited to participate in the study. The registered dental practitioner or registered dental specialist will screen the patient and those who adhere to the inclusion criteria will be invited to participate.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Those who have compromised healing:
- Current usage of steroids /corticosteroids
- Current usage of immunosuppressants, immunomodulators or antiangiogenics
- Current usage of antiresorptive drugs e.g denosumab or current/history of oral/IV bisphosphonates
- Previous history or current head and neck radiation or current chemotherapy
- Smoker
- Diabetic
- Liver disease of kidney disease
- Autoimmune disease
- Short term postoperative analgesia, antibiotics and steroids after dental extraction is permitted
Participants are also deemed ineligible if they have systemic conditions or are taking drugs that could influence pain perception. This includes oro-facial pain disorders, neurological/ cognitive/psychiatric conditions, obstructive sleep apnoea, temporo-mandibular disorders. Other exclusion criteria include those who are pregnant, lack the capacity for consent or those unable to comprehend pain.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple 1 in 3 randomisation using a computerised randomiser generator: https://numbergenerator.org/randomnumbergenerator/1-3
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
All raw data will be converted into a quantitative form for ease of analysis. Analysis will use Graphpad Prism(version 9) and SPSS software (Version 29, IBM Corporation, 2020). Bivariate and multivariate analyses will be conducted to compare measured outcomes. A p value of <0.05 will be used as the threshold for statistical significance. Data will be divided into the two intervention groups.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/07/2025
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
120
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD
Query!
Funding & Sponsors
Funding source category [1]
319041
0
University
Query!
Name [1]
319041
0
The University of Queensland School of Dentistry
Query!
Address [1]
319041
0
Query!
Country [1]
319041
0
Australia
Query!
Primary sponsor type
University
Query!
Name
The University of Queensland School of Dentistry
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
321508
0
Commercial sector/Industry
Query!
Name [1]
321508
0
Dentroid
Query!
Address [1]
321508
0
Query!
Country [1]
321508
0
Australia
Query!
Ethics approval
Ethics application status
Submitted, not yet approved
Query!
Ethics committee name [1]
317649
0
The University of Queensland Human Research Ethics Committee A
Query!
Ethics committee address [1]
317649
0
https://www.uq.edu.au/research/research-support/ethics-integrity-and-compliance/human-ethics
Query!
Ethics committee country [1]
317649
0
Australia
Query!
Date submitted for ethics approval [1]
317649
0
12/05/2025
Query!
Approval date [1]
317649
0
Query!
Ethics approval number [1]
317649
0
Query!
Summary
Brief summary
Fear of pain following dental surgery can cause anxiety and contribute to dental phobia, particularly in relation to dental extractions. In recent years, researchers have explored new methods to reduce postoperative pain associated with these procedures. The purpose of this study is to investigate whether a polychromatic light-emitting diode (LED) device, which emits visible red and near-infrared light, can help reduce pain during the recovery period. This study is being completed as part of Dr Jessica Zachar’s Doctor of Philosophy (PhD). This research is being conducted and sponsored by The University of Queensland.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
141694
0
Dr Jessica Zachar
Query!
Address
141694
0
The University of Queensland, 288 Herston Road, Herston 4006 QLD
Query!
Country
141694
0
Australia
Query!
Phone
141694
0
+61 7 3365 8055
Query!
Fax
141694
0
Query!
Email
141694
0
[email protected]
Query!
Contact person for public queries
Name
141695
0
Jessica Zachar
Query!
Address
141695
0
The University of Queensland, 288 Herston Road, Herston 4006 QLD
Query!
Country
141695
0
Australia
Query!
Phone
141695
0
+61 7 3365 8055
Query!
Fax
141695
0
Query!
Email
141695
0
[email protected]
Query!
Contact person for scientific queries
Name
141696
0
Jessica Zachar
Query!
Address
141696
0
The University of Queensland, 288 Herston Road, Herston 4006 QLD
Query!
Country
141696
0
Australia
Query!
Phone
141696
0
+61 7 3365 8055
Query!
Fax
141696
0
Query!
Email
141696
0
[email protected]
Query!
Data sharing statement
Will the study consider sharing individual participant data?
No
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF